Beijing Fangce Equation Pharmaceutical Sci & Tech

Beijing Fangce Equation Pharmaceutical Sci & Tech is a China-based biotechnology company specializing in the discovery and development of innovative small molecule therapeutics. The company leverages a proprietary computational drug design platform to target challenging protein-protein interactions (PPIs) in oncology and immunology. By integrating structural biology, medicinal chemistry, and artificial intelligence, Fangce Equation aims to develop first-in-class or best-in-class treatments for cancer and other life-threatening diseases. Their pipeline primarily features inhibitors targeting the RAS/MAPK signaling pathway, with lead programs currently in the pre-clinical stage.